Could Low Dose Naltrexone (LDN) Beat Cancer and Auto-Immune Diseases?

May 26, 2009|223,171views

In this interview with Dr. Burton Berkson, he explains how low dose Naltrexone can have amazing effects on arthritis, lupus, and other autoimmune diseases.

I'm sure you received many valuable health tips from this small segment of the expert interview. To hear the full version of this and other interviews I do with world-renowned health experts is easy...

Simply sign up for the affordable Mercola Inner Circle and receive them monthly, with zero effort on your part. Take this small step -- and take control of your health -- 2,302 other Mercola Inner Circle members can't be wrong!

Effortless Healing – One Step at a Time – NOW AVAILABLE!

My newest book, Effortless Healing is now available! I've organized this book into a guide that will help you avoid the many pitfalls of the conventional approach to health. Rather than relying on expensive and potentially dangerous drugs, I will help you effortlessly make small shifts in what you eat and how you live to achieve your health goals. I promise, Effortless Healing isn't a book that will overwhelm you. On top of that, ordering the book today entitles you to 3 exclusive bonuses:

BONUS #1:

A sneak peek of my new book! You won’t need to wait for the book to arrive to get started. Begin reading my new book right away with your free sneak preview!

BONUS #2:

My most popular video interviews, all in one place. I’ve compiled 18 of my BEST expert interviews for you to watch and listen to at your leisure, and in the comfort of your own home or office.

BONUS #3:

Receive 15% off your next Mercola.com order. Depending on your order, your savings from this one bonus alone could more than cover the cost of your book!

All My Profits from This Book Will Be Donated

That's right. When you order a copy of my new book Effortless Healing, you'll be making a much-deserved donation to the key organizations that work quietly and efficiently behind the scenes to make the world a healthier place for you, your family, and your community.

Among them, you'll be benefiting and supporting the actions of:

National Vaccine Information Center (NVIC) – A non-profit organization that seeks to prevent vaccine injuries and deaths through public education and defending your right of informed choice.

Organic Consumers Association (OCA) – A grassroots public interest organization campaigning for health, justice, and sustainability, and addressing food safety, GMOs, the industrial agricultural complex, children's health, and more. The ONLY U.S. organization focused exclusively on the interests that you and I share!

Consumers for Dental Choice – Children, the unborn, and employees in the dental field are particularly vulnerable to mercury. But so is everyone with a mouthful of amalgam fillings (which are 50% mercury) at risk. Consumers for Dental Choice is working to phase out amalgam use and to promote access to mercury-free alternatives.

Fluoride Action Network (FAN) – An international coalition aimed at ending water fluoridation and alerting you to fluoride's environmental and health risks. FAN keeps you informed about fluoride toxicity, and monitors government actions that may expose you to fluoride.

Are you ready to get started? The timing has never been better. Order your copy of Effortless Healing today, collect your free gifts, and let your journey begin!

Dr. Mercola's Comments:

Naltrexone (generic name) has been an FDA approved drug for over 20 years. It’s a pharmacologically active opioid antagonist that is conventionally used to treat drug- and alcohol addiction, normally at doses of 50mg to 300mg.

Added benefits include its low-cost, and few, if any, of the detrimental side effects you normally experience with pharmaceutical drugs.

Treating Autoimmune Diseases With Low Dose Naltrexone (LDN)

Recently I had the pleasure of interviewing Dr. Burton M. Berkson for my Inner Circle,expert interview series, in which he discussed the many uses for LDN, and the phenomenal results he’s been able to achieve in both cancer patients and those with autoimmune diseases.

As is often the case with treatments that work but are inexpensive, very few physicians are aware of LDN.

One major reason is just because there’s very little money in it, so none of the pharmaceutical giants back it. Therefore, there are no friendly sales reps visiting your doctor talking about the potential benefits of Naltrexone in very low doses.

In addition to the conditions already mentioned, LDN is most commonly used for diseases such as:

Hepatitis C

Diabetic neuropathies

Lupus

Dermatomyositis (an inflammatory muscle disease)

Ulcerative colitis

Other autoimmune diseases

Additionally, at least one physician, Dr. Jacquelyn McCandless, has even found LDN to have a positive effect on children with autism.

According to Dr. Berkson, LDN seems to work the best for autoimmune diseases. But he has also published two studies on LDN for the treatment of cancer.

"It is difficult for many to believe that one drug can accomplish so many tasks. But LDN does not treat symptoms as most drugs do. It actually works way "upstream" to modulate the basic mechanisms that result in the disease state."

Even with cancer patients, the survival rate is about 50 percent -- and they are the sickest; oftentimes coming to him for this treatment as a very last resort after everything else failed.

How Does LDN Work?

A growing body of research over the past 20 years indicates that your body’s secretion of endorphins (your internal, natural opioids) play an important, if not central, role in the workings of your immune system.

"Opioid-Induced Immune Modulation: .... Preclinical evidence indicates overwhelmingly that opioids alter the development, differentiation, and function of immune cells, and that both innate and adaptive systems are affected.

The relatively recent identification of opioid-related receptors on immune cells makes it even more likely that opioids have direct effects on your immune system."

Typically, LDN is taken at bedtime, which blocks your opioid receptors for a few hours in the middle of the night. It is believed to up-regulate vital elements of your immune system by increasing your body’s production of metenkephalin and endorphins (your natural opioids), hence improving your immune function.

And, as for LDNs anti-cancer mechanism, Dr. Bernard Bihari – who discovered LDN as a therapeutic agent for AIDS in 1985 -- believes it is likely due to an increase in:

the number and density of opiate receptors on the tumor cell membranes, making them more responsive to the growth-inhibiting effects of the already present levels of endorphins, which in turn induces apoptosis (cell death) in the cancer cells

the absolute numbers of circulating cytotoxic T cells and natural killer cells, as well as killer cell activity

Recent Clinical Studies on Safety and Benefits of LDN for Autoimmune Diseases

In addition to Dr. Berkson’s own research, several other studies have been conducted on the benefits of LDN, and others are in the pipeline.

For a more complete list of past and current research, please see the lowdosenaltrexone.org website, but here are a couple of highlights.

LDN for Multiple Sclerosis – Dr. Maira Gironi, an Italian neurological researcher, treated 40 patients affected with Primary Progressive MS (PPMS) with LDN for six months, concluding that LDN was not only safe and well-tolerated, but halted the progression of the disease in all but one patient. The results from this pilot study were published in the journal Multiple Sclerosis in September 2008.

An impressive two-thirds of the patients in her pilot study went into remission, and 89 percent responded to LDN treatment to some degree. She concluded that “LDN therapy appears effective and safe in subjects with active Crohn’s disease.”

Other studies currently underway in various parts of the world, include:

A Phase II placebo-controlled clinical trial on the efficacy of LDN for children and adolescents with Crohn’s disease at Penn State.

A clinical trial of LDN in HIV-infected citizens of Mali—the first scientific study of LDN for HIV/AIDS in Africa—implemented in October 2007.

A study of LDN in the treatment of MS at the University of California, San Francisco, implemented in early 2007.

A clinical trial of LDN in the treatment of fibromyalgia at Stanford Medical Center implemented in October 2007.

A study by the MindBrain Consortium in Akron, Ohio of, especially, the affective changes in MS treated with LDN, begun late 2007.

An animal research study at Penn State of naltrexone in a model of a disease that mimics MS.

*These statements have not been evaluated by the Food and Drug Administration. This
product is not intended to diagnose, treat, cure or prevent any disease. If you
are pregnant, nursing, taking medication, or have a medical condition, consult your
physician before using this product.

Disclaimer: The entire contents of this website are based upon
the opinions of Dr. Mercola, unless otherwise noted. Individual articles are based
upon the opinions of the respective author, who retains copyright as marked. The
information on this website is not intended to replace a one-on-one relationship
with a qualified health care professional and is not intended as medical advice.
It is intended as a sharing of knowledge and information from the research and experience
of Dr. Mercola and his community. Dr. Mercola encourages you to make your own health
care decisions based upon your research and in partnership with a qualified health
care professional.

If you want to use an article on your site please click here. This content may be copied in full, with copyright,
contact, creation and information intact, without specific permission, when used
only in a not-for-profit format. If any other use is desired, permission in writing
from Dr. Mercola is required.